Corcept Therapeutics
Pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Learn more
Launch date
Employees
Market cap
CAD5.1b
Enterprise valuation
CAD4.4b (Public information from Sep 2024)
Share price
$42.25 CORT
Menlo Park California (HQ)
Authorizing premium user...